Physiologically based absorption modelling to predict the impact of drug properties on pharmacokinetics of bitopertin (Q34099804)

31 July 2017

Physiologically based absorption modelling to predict the impact of drug properties on pharmacokinetics of bitopertin (English)

1 reference

31 July 2017

1 reference

Neil Parrott

1

1 reference

31 July 2017

Dominik Hainzl

2

1 reference

31 July 2017

Emmanuel Scheubel

3

1 reference

31 July 2017

Siegfried Krimmer

4

1 reference

31 July 2017

Christophe Boetsch

5

1 reference

31 July 2017

Elena Guerini

6

1 reference

31 July 2017

Meret Martin-Facklam

7

1 reference

31 July 2017

language of work or name

English

0 references

publication date

27 June 2014

1 reference

31 July 2017

1 reference

31 July 2017

16

1 reference

31 July 2017

1077-1084

1 reference

31 July 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1208/s12248-014-9639-y

31 July 2017

0 references

cites work

The use of modeling tools to drive efficient oral product design

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4147056

Glycine reuptake inhibitor RG1678: a pharmacologic characterization of an investigational agent for the treatment of schizophrenia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4147056

The role of predictive biopharmaceutical modeling and simulation in drug development and regulatory evaluation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4147056

Utility of physiologically based absorption modeling in implementing Quality by Design in drug development

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4147056

Physiologically-based pharmacokinetics in drug development and regulatory science

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4147056

Selective GlyT1 inhibitors: discovery of [4-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a promising novel medicine to treat schizophrenia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4147056

Glycine transport inhibitors for the treatment of schizophrenia: symptom and disease modification

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4147056

Drug absorption modeling as a tool to define the strategy in clinical formulation development

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4147056

Pharmaceutical quality by design: product and process development, understanding, and control

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4147056

Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4147056

A strategy for preclinical formulation development using GastroPlus as pharmacokinetic simulation tool and a statistical screening design applied to a dog study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4147056

Predicting the impact of physiological and biochemical processes on oral drug bioavailability

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4147056

Physiologically based pharmacokinetic modelling to predict single- and multiple-dose human pharmacokinetics of bitopertin

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4147056

A physiologically based pharmacokinetic (PBPK) approach to evaluate pharmacokinetics in patients with cancer

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4147056

A glimmer of light for neuropsychiatric disorders.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4147056

Applications of physiologically based absorption models in drug discovery and development.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4147056

Dissolution modeling: factors affecting the dissolution rates of polydisperse powders.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4147056

Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24970349

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1208/S12248-014-9639-Y

1 reference

Dimensions Publication ID

31 July 2017

0 references

1 reference

31 July 2017

1 reference